Document Detail


Topical testosterone propionate in the therapy of vulvar dystrophies.
MedLine Citation:
PMID:  6698055     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
187 patients with atrophic, hypertrophic and mixed vulvar dystrophy were treated with 2% testosterone propionate ointment from 18 months to 7 years. Symptoms, macroscopic, and histologic picture were evaluated before and during treatment. About 75% of the patients achieved good and excellent symptom relief. Treatment efficacy differentiates according to the type of dystrophy, and in relation to the lesion's extension and the duration of symptoms, which consist mostly of pruritus. Side effects from therapy were negligible.
Authors:
A Ambrosini; L Becagli; F Scrimin; D De Salvia; P Resta; M Gambato
Related Documents :
20347665 - Current concepts in systemic and topical therapy for superficial mycoses.
16488335 - Etanercept monotherapy in patients with psoriasis: a summary of safety, based on an int...
19848315 - 5-aminolaevulinic acid-photodynamic therapy for the treatment of cervical condylomata a...
12707465 - Long-term continuous versus intermittent cyclosporin: therapy for psoriasis.
22176875 - Thoracic endovascular repair (tevar) in the management of aortic arch pathology.
19415535 - 5-fluorouracil induces arterial vasoconstrictions but does not increase angiotensin ii ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of gynaecological oncology     Volume:  5     ISSN:  0392-2936     ISO Abbreviation:  Eur. J. Gynaecol. Oncol.     Publication Date:  1984  
Date Detail:
Created Date:  1984-04-04     Completed Date:  1984-04-04     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8100357     Medline TA:  Eur J Gynaecol Oncol     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  58-63     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Adult
Aged
Chronic Disease
Female
Humans
Middle Aged
Testosterone / administration & dosage*
Vulvar Diseases / diagnosis,  drug therapy*,  pathology
Chemical
Reg. No./Substance:
58-22-0/Testosterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunodiagnosis in gynaecologic oncology: possibilities and limitations.
Next Document:  Manometric study on anal sphyncteres and intestinal MTT before and after extensive surgery on patien...